Skip Navigation

COVID-19 Update

We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Gregory Michael Pontone, M.D.

Headshot of Gregory Michael Pontone
  • Director, Parkinson's Disease Neuropsychiatry Clinic
  • Associate Professor of Psychiatry and Behavioral Sciences


Adult Psychiatry, Alzheimer's Disease (AD), Dementia, Geriatric Psychiatry, Neuropsychiatric Complications of Movement Disorders, Neuropsychiatry, Parkinson's Disease, Psychiatric Complications of Neurological Diseases, Psychiatry, Psychiatry and Behavioral Sciences more

Research Interests

Neuropsychiatric complications of Parkinson's disease more

Request an Appointment

Insurance Information

Maryland Phone


Outside of Maryland

Request Appointment

International Patients

Request Appointment


The Johns Hopkins Hospital

Appointment Phone: 410-502-2981
600 N. Wolfe Street
Phipps Suite 300
Baltimore, MD 21287 map
Phone: 410-502-0477 | Fax: 410-614-3676


Gregory Pontone, M.D., M.H.S. is an Associate Professor in the Department of Psychiatry at Johns Hopkins University School of Medicine in Baltimore, Maryland. After completing a medicine internship and residency training in psychiatry at Johns Hopkins, Dr. Pontone completed a two-year fellowship in geriatric psychiatry and movement disorders focusing on Parkinson’s disease through the Clinical Research Program of the Morris K. Udall Parkinson’s Disease Research Center at Johns Hopkins. He also completed a fellowship in Clinical Trial Methods in Neurology sponsored by theNational Institute of Neurological Disorders and Stroke.He is board certified by the American Board of Psychiatry and Neurology and has an added certification in the specialty of geriatric psychiatry. He serves on the standards committee of an international consortium of Parkinson's disease researchers, the Parkinson Study Group.

He is currently an Attending Psychiatrist in the Geriatric and Neuropsychiatry division where he treats patients with neurodegenerative disorders (including Parkinson’s disease and related disorders, Alzheimer’s dementia), and behavioral disturbances resulting from these diseases.  Dr. Pontone is the director of the Johns Hopkins Parkinson’s disease Neuropsychiatry Clinic, which focuses on diagnosing and treating the neuropsychiatric aspects of Parkinson’s disease and related disorders. His research focuses on the interaction between neuropsychiatric symptoms such as cognitive impairment, anxiety, and depression and motor impairment in Parkinson’s disease. more


  • Director, Parkinson's Disease Neuropsychiatry Clinic
  • Associate Professor of Psychiatry and Behavioral Sciences
  • Associate Professor of Neurology

Departments / Divisions

Centers & Institutes



  • MD; University of South Florida Morsani College of Medicine (2002)


  • Psychiatry; Johns Hopkins University School of Medicine (2006)


  • Geriatric Psychiatry; Johns Hopkins University School of Medicine (2008)

Board Certifications

  • American Board of Psychiatry and Neurology (Geriatric Psychiatry) (2010)
  • American Board of Psychiatry And Neurology (Psychiatry) (2007)

Research & Publications

Clinical Trial Keywords

Anxiety disorders in Parkinson''s disease

Selected Publications

View all on PubMed

Pontone GM, Bakker CC, Chen S, Mari Z, Marsh L, Rabins PV, Williams JR, Bassett SS. The longitudinal impact of depression on disability in Parkinson disease. International Journal of Geriatric Psychiatry. 2016 May;31(5):458-65. PMID: 26284815

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15;24(9):1333-8. PubMed PMID: 19425086;  PubMed Central PMCID: PMC2830642

Pontone GM, Palanci J, Bienvenu OJ, Liang KY, Nestadt G, Rabins PV, Williams JR, Marsh L. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):417-24. PubMed PMID: 22231313; PubMed Central PMCID: PMC3547673

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. PubMed PMID: 23567419; PubMed Central PMCID: PMC3655116

Pontone GM, Williams J, Anderson K, Chase G, Goldstein S, Grill S, Hirsch E, Lehmann S, Little J, Margolis R, Rabins P, Weiss H, Marsh L. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism and Related Disorders 2011;17(4):249-254

Activities & Honors


  • American Association for Geriatric Psychiatry
  • Parkinson Study Group Standards Committee

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button